Sort
39,280 grants matching “leukemia”
Optimizing the graft versus leukemia effect for pediatric ALL
$414,815Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Project 3: Single Cell Measures of Intratumor Diversity for Optimal Breast Cancer Therapy
$414,812Kornelia Polyak · Dana-Farber Cancer Inst · U54 · FY2017 · CA
Oncogenic NOTCH Signaling: Mouse Modeling
$414,809Warren S Pear · Brigham And Women'S Hospital · P01 · FY2009 · CA
MOLECULAR STUDIES OF HEMATOPOIETIC STEM CELLS
$414,771Princeton University · R37 · FY2005 · DK
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD
$414,766Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2000 · CA
MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
$414,751Leo Luznik · Johns Hopkins University · R01 · FY2015 · HL
Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer
$414,691Jane Amanda Skok · New York University School Of Medicine · P01 · FY2021 · CA
Development of a Production Method for Scaling Up Lentiviral Vector Manufacture
$414,658Madhusudan Viswanath Peshwa · Maxcyte, Inc. · R44 · FY2008 · HL
Structure-guided cancer immunotherapy design with HLA-Arena and CrossDome
$414,649Dinler Antunes · University Of Houston · R21 · FY2024 · CA
Community Outreach and Engagement
$414,637Lourdes Baezconde Garbanati · University Of Southern California · P30 · FY2022 · CA
Functional Genomic Dissection of Refractory Anemia
$414,588Benjamin Levine Ebert · Brigham And Women'S Hospital · R01 · FY2011 · HL
Mechanisms of Hematopoietic Stem Cell Transformation
$414,526Emmanuelle Passegue · University Of California, San Francisco · R01 · FY2014 · HL
Molecular analysis of yeast lsw1 and lsw2 complexes
$414,469Fred Hutchinson Cancer Research Center · R01 · FY2004 · GM
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$414,368Aasthaa Bansal · University Of Washington · R37 · FY2018 · CA
GENETIC ANALYSIS OF GENES CONTROLLING A POSITION EFFECT
$414,248Jasper D Rine · University Of California Berkeley · R37 · FY2008 · GM
Effector T-cell trafficking in graft-versus-host disease
$414,245Ran Reshef · Columbia University Health Sciences · R01 · FY2019 · HL
Residue-by-residue details of FUS protein phase separation and aggregation
$414,211Nicolas Lux Fawzi · Brown University · R01 · FY2022 · GM
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$414,188Yin Wang · University Of Maryland Baltimore · R01 · FY2021 · CA
Flow Cytometric Evaluation of Biomarkers
$414,187Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Project 1: Ionic Modulation of Chromatin in Cancer
$414,183Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2015 · CA
Chromatin Modifications by Histone Ubiquitination and Methylations
$414,179Ali Shilatifard · Northwestern University At Chicago · R01 · FY2015 · GM
The Biology of Promyelocytic Leukemia in a Mouse Model
$414,160Timothy J Ley · Washington University · R01 · FY2009 · CA
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$414,159Paul Trippier · University Of Nebraska Medical Center · R01 · FY2021 · CA
Molecular biology of myeloid differentiation
$414,120Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2013 · HL
DESIGN OF NOVEL COMPLEMENT INHIBITORS
$414,093John D Lambris · University Of Pennsylvania · P01 · FY2008 · AI